Following CE Mark approval, Quantum Surgical announces the commercial launch of Epione® its medical robot dedicated to liver cancer
[Epione® the medical robot dedicated to liver cancer] Montpellier, France, September 7, 2021 - Quantum Surgical, an innovative medical robotics company, announces that it has recently obtained CE mark approval for Epi-one®, its robot designed for minimally invasive treatment of abdominal tumors. This authorization allows the commercial launch of Epione® on the European market. Epione® is a robotic solution developed to help physicians perform safer and more ef-fective percutaneous ablations in the abdomen, a minimally invasive treatment in which a needle is inserted through the skin